Results 101 to 110 of about 2,440 (155)

Parental acceptance of typhoid conjugate vaccine for children aged 6 months to 15 years in an outbreak setting of Lyari Town Karachi, Pakistan. [PDF]

Vaccine, 2023
Batool R, Yousafzai MT, Qureshi S, Muhammad S, Qazi I, Sadaf T, Ashorn P, Qamar FN.   +7 more
europepmc   +1 more source

From Crisis to Control: A Study of Typhoid Conjugate Vaccine Efficacy in Harare, Zimbabwe (2017-2024). [PDF]

Open Forum Infect Dis
Bvochora T, Manyara J, Thilliez G, Vere M, Mukeredzi I, Nhamo D, Chitiyo F, Muzondo A, Juru A, Chonzi P, Phiri I, Smith AM, Chaibva BV, Mapingure M, Fuller W, Shrestha P, Nair P, Kingsley RA, Laxminarayan R, Musuka G, Mashe T.   +20 more
europepmc   +1 more source

Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness. [PDF]

Vaccine, 2023
Burrows H, Antillón M, Gauld JS, Kim JH, Mogasale V, Ryckman T, Andrews JR, Lo NC, Pitzer VE.   +8 more
europepmc   +1 more source

Examining epidemiological models and economic analyses of typhoid conjugate vaccine: A scoping review. [PDF]

PLOS Glob Public Health
Mandaliya P, Orangi S, Kazungu J, Waithaka D, Kairu A, Bationo A, Masiye F, Onwujekwe O, Barasa E.   +8 more
europepmc   +1 more source

Correction: Impact of the COVID-19 pandemic and typhoid conjugate vaccine introduction on typhoid fever in Nepal. [PDF]

PLoS Negl Trop Dis
Tamrakar D, Naga SR, Jung E, Shrestha B, Bista Roka P, Pokharel R, Shahi SB, Bajracharya AT, Mahadup SK, Katuwal N, Doyle K, Seidman JC, Carter AS, Luby SP, Bogoch II, Aiemjoy K, Garrett DO, Shrestha R, Andrews JR.   +18 more
europepmc   +1 more source

Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward. [PDF]

Open Forum Infect Dis, 2023
Russell AL, Hampton LM, Sinha A, Luquero FJ, Abdelwahab J.   +4 more
europepmc   +1 more source

Durable Anti-Vi IgG and IgA Antibody Responses in 15-Month-Old Children Vaccinated With Typhoid Conjugate Vaccine in Burkina Faso. [PDF]

J Pediatric Infect Dis Soc, 2023
Ouedraogo A, Diarra A, Nébié I, Barry N, Kabore JM, Tiono AB, Datta S, Liang Y, Mayo I, Oshinsky JJ, Tracy JK, Girmay T, Pasetti MF, Jamka LP, Neuzil KM, Sirima SB, Laurens MB.   +16 more
europepmc   +1 more source

Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India. [PDF]

PLOS Glob Public Health, 2023
Song D, Pallas SW, Shimpi R, Ramaswamy N, Haldar P, Harvey P, Bhatnagar P, Katkar A, Jayaprasad N, Kunwar A, Bahl S, Morgan W, Hutubessy R, Date K, Mogasale V.   +14 more
europepmc   +1 more source

Advancing typhoid conjugate vaccine implementation in Asia: Regional policy priorities. [PDF]

Vaccine
Carter AS, Steele D, John J, Saha S, Laurens MB, Minta AA, Volavola L, Moedjito I, Phounphenghack K, Mahat D, Nyein SL, Gautam A, Sespeñe MFVS, Pati T, Huong NTT, Gupta N, George LS, Jayaprakasam M, Gupta A, Garrett DO.   +19 more
europepmc   +1 more source

Coverage survey of typhoid conjugate vaccine among children aged 6 months to 15 years in an urban slum settlement of Lyari Town Karachi, Pakistan. [PDF]

PLoS One, 2023
Batool R, Qureshi S, Haq Z, Yousafzai MT, Salam RA, Ali R, Sadaf T, Ali M, Qamar FN.   +8 more
europepmc   +1 more source